PLSCR3 Antibodies

Santa Cruz Biotechnology offers a broad range of PLSCR3 monoclonal antibodies for investigating phospholipid scramblase 3 (PLSCR3) in various biological processes. PLSCR3 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PLSCR3 plays a vital role in regulating membrane dynamics and cell signaling, particularly in processes such as apoptosis and immune response. The phospholipid translocation function of PLSCR3 maintains cellular homeostasis and facilitates cell communication. Research focused on PLSCR3 mechanisms can enhance understanding of various diseases, including cancer and autoimmune disorders. Scientists worldwide utilize PLSCR3 monoclonal antibodies to explore cellular pathways and molecular interactions. Ongoing studies of PLSCR3 continue to reveal new insights into cell biology and disease progression. Research conducted with PLSCR3 monoclonal antibodies has led to significant discoveries in cell signaling pathways. Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to scientific knowledge and advance therapeutic developments.